Nontransformed cells depend on growth factors for their survival, proliferation and differentiation. In addition to polypeptide growth factors, an emerging group of naturally occurring group of lipid mediators, named phospholipid growth factors (PLGF) have been discovered. Within this group, lysophosphatidic acid (1-acyl-2-lyso-sn- glycero-3-phosphate, LPA), nature's simplest phospholipid, was found to elicit growth factor-like effects in almost every cell type spanning the phylogenetic tree, from Dictyostelium to humans. A structurally unrelated sphingolipid, sphingosine-l-phosphate also possesses PLGF- like effects. The immediate objective of this work is to understand how receptor structure defines ligand selectivity in the endothelial differentiation gene (EDG) PLGF receptor family. The EDG gene family, is a gene family which encodes PLGF receptors and currently consists of eight G protein-coupled receptors recognizing either lysophosphatidic acid or sphingosine-1-phosphate. Here we propose a mutagenesis based approach to understanding receptor ligand interactions in the EDG family which is guided by computational modeling, ligand binding, and receptor function studies. These experimental studies will refine and validate high-resolution molecular models of the individual EDG receptors, which can then be used to achieve our long-term goal aimed at developing therapeutically applicable PLGF analogs. This is an interdisciplinary proposal, which builds on the expertise of the PI in PLGF receptors and PLGF pharmacology and brings it together with the expertise of Dr. Abby Parrill in computational chemistry and of Dr. Duane Miller in synthetic lipid chemistry.
Three specific aims will be pursued: 1. Develop and validate a refined computational model for the interaction of SPP with the EDG1 receptor. 2. Identify residues conferring specificity for sphingolipids in the EDG3/5/6/8 receptor subfamily. 3. Identify residues involved in glycerolipid recognition in the EDG2/4/7 receptor subfamily.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
3R01CA092160-05S1
Application #
7106851
Study Section
Medical Biochemistry Study Section (MEDB)
Program Officer
Ogunbiyi, Peter
Project Start
2001-08-01
Project End
2006-07-31
Budget Start
2005-08-01
Budget End
2006-07-31
Support Year
5
Fiscal Year
2005
Total Cost
$65,970
Indirect Cost
Name
University of Tennessee Health Science Center
Department
Physiology
Type
Schools of Medicine
DUNS #
941884009
City
Memphis
State
TN
Country
United States
Zip Code
38163
Dancs, Péter Tibor; Ruisanchez, Éva; Balogh, Andrea et al. (2017) LPA1 receptor-mediated thromboxane A2 release is responsible for lysophosphatidic acid-induced vascular smooth muscle contraction. FASEB J 31:1547-1555
Lin, Kuan-Hung; Ho, Ya-Hsuan; Chiang, Jui-Chung et al. (2016) Pharmacological activation of lysophosphatidic acid receptors regulates erythropoiesis. Sci Rep 6:27050
Ragle, Lauren E; Palanisamy, Dilip J; Joe, Margaux J et al. (2016) Discovery and synthetic optimization of a novel scaffold for hydrophobic tunnel-targeted autotaxin inhibition. Bioorg Med Chem 24:4660-4674
Knowlden, Sara A; Hillman, Sara E; Chapman, Timothy J et al. (2016) Novel Inhibitory Effect of a Lysophosphatidic Acid 2 Agonist on Allergen-Driven Airway Inflammation. Am J Respir Cell Mol Biol 54:402-9
Deng, Wenlin; Kimura, Yasuhiro; Gududuru, Veeresh et al. (2015) Mitigation of the hematopoietic and gastrointestinal acute radiation syndrome by octadecenyl thiophosphate, a small molecule mimic of lysophosphatidic acid. Radiat Res 183:465-75
Lee, Sue-Chin; Fujiwara, Yuko; Liu, Jianxiong et al. (2015) Autotaxin and LPA1 and LPA5 receptors exert disparate functions in tumor cells versus the host tissue microenvironment in melanoma invasion and metastasis. Mol Cancer Res 13:174-85
Zhao, Guannan; Guo, Yuqi; Chen, Zixuan et al. (2015) miR-203 Functions as a Tumor Suppressor by Inhibiting Epithelial to Mesenchymal Transition in Ovarian Cancer. J Cancer Sci Ther 7:34-43
Balogh, Andrea; Shimizu, Yoshibumi; Lee, Sue Chin et al. (2015) The autotaxin-LPA2 GPCR axis is modulated by ?-irradiation and facilitates DNA damage repair. Cell Signal 27:1751-62
Parham, Kate A; Zebol, Julia R; Tooley, Katie L et al. (2015) Sphingosine 1-phosphate is a ligand for peroxisome proliferator-activated receptor-? that regulates neoangiogenesis. FASEB J 29:3638-53
Lee, Sue-Chin; Fujiwara, Yuko; Tigyi, Gabor J (2015) Uncovering unique roles of LPA receptors in the tumor microenvironment. Receptors Clin Investig 2:

Showing the most recent 10 out of 91 publications